Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.48 million versus the consensus estimate of $48.63 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.